Revenue from operations rose 2.4% YoY, reaching ₹1,405.8 Crore, up from ₹1,373.4 Crore in the previous fiscal’s corresponding ...

Gland Pharma in Q2FY25 reports Rs. 1,405.8 crore revenue and profit dip by 16% at Rs.163.5 crore: Our Bureau, Bengaluru Tuesday, November 5, 2024, 16:15 Hrs [IST] Gland Pharma, a ...

Data: SHFE, DCE market movement (Nov 08) Significant Decrease in Stainless Steel Arrivals, 300-Series Social Inventory Down 1.4% [SMM Analysis] [SMM Analysis] Ternary Cathode Precursor Market Analysis ...